Clinical Trial Update: Interaction Between Reboxetine and 3,4-Methylenedioxymethamphetamine: Pharmacodynamics (PD) and Pharmacokinetics (PK) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pharmacodynamic and pharmacokinetic interactions between reboxetine and MDMA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amphetamine-related Disorders
• Mood Disorders
• Substance-related Disorders

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)
• Reboxetine (Reboxetine)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Mood Disorder, Substance-related Disorders | Phase 1 | Status: COMPLETED